What is the TherapeuticsMD Inc. stock price forecast?

TherapeuticsMD Inc. is currently trading at $2.29. View real-time AI analysis on Alpha Lenz.

What is TherapeuticsMD Inc. insider trading activity?

View the latest insider trading data for TherapeuticsMD Inc. on Alpha Lenz.

What is TherapeuticsMD Inc.'s P/E ratio?

View TherapeuticsMD Inc.'s valuation metrics on Alpha Lenz.

TherapeuticsMD Inc.

NASDAQ · TXMD

$2.29+0.01(+0.44%)Pre-market

Ask about TherapeuticsMD Inc.'s future dividend policy...

Alpha Chat Insight

“TherapeuticsMD Inc.'s ROE is -2.1%. Explore profitability and growth together.”

Ask for details →

Company Overview

TherapeuticsMD Inc. operates within the pharmaceutical industry, primarily focused on the development and commercialization of products that address the specific healthcare needs of women. Its product portfolio includes hormone therapy solutions for menopause symptom management, as well as prenatal vitamins. These products are designed to provide targeted relief and essential nutrients, enhancing the quality of life for women undergoing significant hormonal changes. With a keen focus on innovation and women's health, TherapeuticsMD Inc. plays a vital role in advancing medical solutions for conditions traditionally underrepresented in pharmaceutical research. By operating in a crucial healthcare niche, the company supports the ongoing growth and diversification of women's healthcare options, impacting both patient outcomes and broader industry standards.

Websitehttps://www.therapeuticsmd.com

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Employees1

Company Statistics

FY 2025

Profile

N/AMarket Cap

$3.02MRevenue

0.00Shares Out

1Employees

Margins

N/AGross

-94.14%EBITDA

-139.44%Operating

-21.61%Pre-Tax

-18.83%Net

Valuation

N/AP/E

N/AP/B

N/AEV/Sales

N/AEV/EBITDA

N/AP/FCF

Growth (CAGR)

-64.91%Rev 3Yr

-45.84%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-1.49%ROA

-2.10%ROE

-11.02%ROIC

Financial Health

$7.48MCash & Cash Equivalents

$3.30MNet Debt

40.11%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“TherapeuticsMD Inc.'s ROE is -2.1%. Explore profitability and growth together.”

Ask for details →

Frequently Asked Questions

TherapeuticsMD Inc. (ticker: TXMD) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 1 employees.

The current price is $2.29 with a P/E ratio of -x and P/B of -x.

ROE is -2.10% and operating margin is -139.44%. Annual revenue is $3M.